Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.49819958 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.49819958 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.99198777 |
4 | positive regulation of B cell differentiation (GO:0045579) | 5.77732307 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.70757029 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.69300179 |
7 | B cell receptor signaling pathway (GO:0050853) | 5.39177524 |
8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.76572332 |
9 | Golgi transport vesicle coating (GO:0048200) | 4.69944297 |
10 | COPI coating of Golgi vesicle (GO:0048205) | 4.69944297 |
11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.69846023 |
12 | regulation of B cell differentiation (GO:0045577) | 4.37930623 |
13 | germ cell migration (GO:0008354) | 4.27984515 |
14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19014608 |
15 | cell adhesion mediated by integrin (GO:0033627) | 4.06689357 |
16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05147004 |
17 | protein localization to endosome (GO:0036010) | 3.98487528 |
18 | negative regulation of granulocyte differentiation (GO:0030853) | 3.98451101 |
19 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.97906009 |
20 | macrophage activation involved in immune response (GO:0002281) | 3.93060036 |
21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.91573415 |
22 | modulation by symbiont of host immune response (GO:0052553) | 3.91573415 |
23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.91573415 |
24 | modulation by symbiont of host defense response (GO:0052031) | 3.91573415 |
25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.91573415 |
26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.91573415 |
27 | definitive hemopoiesis (GO:0060216) | 3.89734831 |
28 | natural killer cell differentiation (GO:0001779) | 3.89263038 |
29 | positive regulation of histone deacetylation (GO:0031065) | 3.80852620 |
30 | skin morphogenesis (GO:0043589) | 3.80404211 |
31 | cellular extravasation (GO:0045123) | 3.77907700 |
32 | negative regulation of phagocytosis (GO:0050765) | 3.76786688 |
33 | hepatocyte apoptotic process (GO:0097284) | 3.63792179 |
34 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.60232639 |
35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50582748 |
36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.48777557 |
37 | negative regulation of B cell proliferation (GO:0030889) | 3.47632415 |
38 | mannose metabolic process (GO:0006013) | 3.45482249 |
39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.44471323 |
40 | protein retention in ER lumen (GO:0006621) | 3.39144354 |
41 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.34341751 |
42 | desmosome organization (GO:0002934) | 3.29317704 |
43 | tolerance induction (GO:0002507) | 3.27201193 |
44 | COPII vesicle coating (GO:0048208) | 3.24438565 |
45 | glutamate secretion (GO:0014047) | 3.23117756 |
46 | negative regulation of bone resorption (GO:0045779) | 3.22288316 |
47 | vesicle coating (GO:0006901) | 3.17607559 |
48 | T cell homeostasis (GO:0043029) | 3.16324976 |
49 | pinocytosis (GO:0006907) | 3.11903474 |
50 | positive regulation of lamellipodium assembly (GO:0010592) | 3.08561024 |
51 | mesodermal cell differentiation (GO:0048333) | 3.08344629 |
52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05674915 |
53 | positive regulation of interferon-alpha production (GO:0032727) | 3.05416750 |
54 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.03829292 |
55 | lymphocyte homeostasis (GO:0002260) | 3.01148686 |
56 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.00761993 |
57 | regulation of interferon-alpha production (GO:0032647) | 3.00414445 |
58 | negative regulation of complement activation (GO:0045916) | 3.00316179 |
59 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.99220958 |
60 | positive regulation of receptor recycling (GO:0001921) | 2.96252520 |
61 | positive regulation of protein deacetylation (GO:0090312) | 2.94084445 |
62 | regulation of granulocyte differentiation (GO:0030852) | 2.93903268 |
63 | angiogenesis involved in wound healing (GO:0060055) | 2.93655582 |
64 | embryonic hemopoiesis (GO:0035162) | 2.93039319 |
65 | regulation of erythrocyte differentiation (GO:0045646) | 2.92302451 |
66 | B cell homeostasis (GO:0001782) | 2.92101324 |
67 | negative regulation of protein activation cascade (GO:2000258) | 2.91455882 |
68 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.91143154 |
69 | macroautophagy (GO:0016236) | 2.89608131 |
70 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.89568239 |
71 | megakaryocyte development (GO:0035855) | 2.89015571 |
72 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.87771858 |
73 | negative regulation of cell killing (GO:0031342) | 2.86734260 |
74 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86734260 |
75 | neutrophil activation involved in immune response (GO:0002283) | 2.86072830 |
76 | immunoglobulin mediated immune response (GO:0016064) | 2.85713463 |
77 | hemidesmosome assembly (GO:0031581) | 2.84660929 |
78 | cellular copper ion homeostasis (GO:0006878) | 2.83119706 |
79 | iron ion import (GO:0097286) | 2.82346808 |
80 | platelet degranulation (GO:0002576) | 2.81426151 |
81 | protein maturation by protein folding (GO:0022417) | 2.79193595 |
82 | regulation of metalloenzyme activity (GO:0048552) | 2.77837223 |
83 | synaptic vesicle maturation (GO:0016188) | 2.76938558 |
84 | response to laminar fluid shear stress (GO:0034616) | 2.76876589 |
85 | microglial cell activation (GO:0001774) | 2.76252378 |
86 | cellular response to zinc ion (GO:0071294) | 2.74522169 |
87 | neutrophil activation (GO:0042119) | 2.73355592 |
88 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.73298195 |
89 | Peyers patch development (GO:0048541) | 2.73298195 |
90 | mature B cell differentiation (GO:0002335) | 2.72993973 |
91 | barbed-end actin filament capping (GO:0051016) | 2.71565756 |
92 | leukocyte homeostasis (GO:0001776) | 2.71545269 |
93 | myeloid cell activation involved in immune response (GO:0002275) | 2.66871102 |
94 | positive regulation of lamellipodium organization (GO:1902745) | 2.66855253 |
95 | response to interleukin-15 (GO:0070672) | 2.66093037 |
96 | cortical actin cytoskeleton organization (GO:0030866) | 2.64591151 |
97 | membrane raft organization (GO:0031579) | 2.63911784 |
98 | response to host (GO:0075136) | 2.63607391 |
99 | response to host defenses (GO:0052200) | 2.63607391 |
100 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.63607391 |
101 | extracellular fibril organization (GO:0043206) | 2.62750361 |
102 | substrate-dependent cell migration (GO:0006929) | 2.62678888 |
103 | positive regulation of chemokine secretion (GO:0090197) | 2.62001719 |
104 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.61199084 |
105 | positive regulation of actin filament depolymerization (GO:0030836) | 2.60191441 |
106 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.58256512 |
107 | cellular potassium ion homeostasis (GO:0030007) | 2.57354075 |
108 | cellular hyperosmotic response (GO:0071474) | 2.56816350 |
109 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.55946853 |
110 | regulation of B cell proliferation (GO:0030888) | 2.54838178 |
111 | positive regulation of Rap GTPase activity (GO:0032854) | 2.54564686 |
112 | B cell proliferation (GO:0042100) | 2.53990260 |
113 | protein hydroxylation (GO:0018126) | 2.53625505 |
114 | response to host immune response (GO:0052572) | 2.53536490 |
115 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.53536490 |
116 | regulation of superoxide anion generation (GO:0032928) | 2.52372789 |
117 | negative regulation of stress fiber assembly (GO:0051497) | 2.51426496 |
118 | lymph vessel development (GO:0001945) | 2.48902302 |
119 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.48624397 |
120 | regulation of receptor recycling (GO:0001919) | 2.48346648 |
121 | fibrinolysis (GO:0042730) | 2.48150239 |
122 | basement membrane organization (GO:0071711) | 2.47952247 |
123 | macrophage activation (GO:0042116) | 2.47884141 |
124 | negative regulation of bone remodeling (GO:0046851) | 2.47607355 |
125 | erythrocyte maturation (GO:0043249) | 2.47309317 |
126 | peptidyl-proline hydroxylation (GO:0019511) | 2.47299863 |
127 | positive regulation of granulocyte differentiation (GO:0030854) | 2.46936744 |
128 | positive regulation of macrophage differentiation (GO:0045651) | 2.46491656 |
129 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.45647632 |
130 | macrophage differentiation (GO:0030225) | 2.45488554 |
131 | granulocyte activation (GO:0036230) | 2.45472637 |
132 | positive regulation of blood coagulation (GO:0030194) | 2.44993268 |
133 | positive regulation of hemostasis (GO:1900048) | 2.44993268 |
134 | sodium ion export (GO:0071436) | 2.44675971 |
135 | actin filament depolymerization (GO:0030042) | 2.44534004 |
136 | fibril organization (GO:0097435) | 2.43372125 |
137 | germinal center formation (GO:0002467) | 2.43059900 |
138 | cell-substrate junction assembly (GO:0007044) | 2.42819293 |
139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.42622247 |
140 | regulation of phagocytosis (GO:0050764) | 2.42253960 |
141 | import into cell (GO:0098657) | 2.42090160 |
142 | positive thymic T cell selection (GO:0045059) | 2.41851653 |
143 | adaptation of signaling pathway (GO:0023058) | 2.41486256 |
144 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.41354955 |
145 | lymph node development (GO:0048535) | 2.41099623 |
146 | response to protozoan (GO:0001562) | 2.40708806 |
147 | negative regulation of interleukin-6 production (GO:0032715) | 2.40656570 |
148 | hypotonic response (GO:0006971) | 2.39734199 |
149 | Golgi to plasma membrane protein transport (GO:0043001) | 2.39588721 |
150 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.39128981 |
151 | mast cell activation (GO:0045576) | 2.38675739 |
152 | type B pancreatic cell proliferation (GO:0044342) | 2.38384070 |
153 | positive regulation of coagulation (GO:0050820) | 2.38072464 |
154 | regulation of early endosome to late endosome transport (GO:2000641) | 2.36464320 |
155 | endocrine hormone secretion (GO:0060986) | 2.35794879 |
156 | stress fiber assembly (GO:0043149) | 2.32339345 |
157 | endodermal cell differentiation (GO:0035987) | 2.32162963 |
158 | regulation of protein localization to plasma membrane (GO:1903076) | 2.32088691 |
159 | negative regulation of fibrinolysis (GO:0051918) | 2.32003968 |
160 | membrane budding (GO:0006900) | 2.31274552 |
161 | regulation of extracellular matrix disassembly (GO:0010715) | 2.29787329 |
162 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.24910151 |
163 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.23274112 |
164 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.22902038 |
165 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.22272176 |
166 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.21115018 |
167 | positive regulation of fibroblast migration (GO:0010763) | 2.20693898 |
168 | protein targeting to plasma membrane (GO:0072661) | 2.19448342 |
169 | clathrin coat assembly (GO:0048268) | 2.18520393 |
170 | endocytic recycling (GO:0032456) | 2.17244080 |
171 | regulation of plasminogen activation (GO:0010755) | 2.16075330 |
172 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.15089320 |
173 | apoptotic cell clearance (GO:0043277) | 2.13990458 |
174 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.12332958 |
175 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.12152877 |
176 | protein carboxylation (GO:0018214) | 2.12152877 |
177 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.12110463 |
178 | Golgi to plasma membrane transport (GO:0006893) | 2.11727550 |
179 | establishment of protein localization to plasma membrane (GO:0090002) | 2.11587347 |
180 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.10862386 |
181 | negative regulation of humoral immune response (GO:0002921) | 2.10718475 |
182 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.09651935 |
183 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.08911672 |
184 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.08773482 |
185 | positive regulation of muscle hypertrophy (GO:0014742) | 2.08773482 |
186 | response to gravity (GO:0009629) | 2.07751618 |
187 | cell-matrix adhesion (GO:0007160) | 2.07657326 |
188 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.06839205 |
189 | positive regulation of wound healing (GO:0090303) | 2.06540413 |
190 | regulation of fibrinolysis (GO:0051917) | 2.05419071 |
191 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.05347001 |
192 | hemoglobin metabolic process (GO:0020027) | 2.04793377 |
193 | regulation of complement activation (GO:0030449) | 2.04573998 |
194 | synaptic vesicle exocytosis (GO:0016079) | 2.04554939 |
195 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.03585923 |
196 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.02481539 |
197 | mating behavior (GO:0007617) | 2.02060506 |
198 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.02007721 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.25557617 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.77262648 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 3.58907501 |
4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.57238717 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56328142 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.38551646 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34968732 |
8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.29485597 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.28536055 |
10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.24028469 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.10050235 |
12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.07474470 |
13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.89115726 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86177073 |
15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.80327141 |
16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74885229 |
17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.73398550 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66370257 |
19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63283967 |
20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58867523 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55317298 |
22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54861525 |
23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.53102096 |
24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48968385 |
25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.44968616 |
26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38472135 |
27 | MAF_26560356_Chip-Seq_TH1_Human | 2.37178558 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.35494451 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 2.34629674 |
30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.29958854 |
31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.27111383 |
32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.26000738 |
33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25250869 |
34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.21925867 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.17548787 |
36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.13161657 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 2.12542501 |
38 | MYB_26560356_Chip-Seq_TH1_Human | 2.11019631 |
39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.09507676 |
40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09054368 |
41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.08338029 |
42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05428735 |
43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96352061 |
44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.94848170 |
45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94643276 |
46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.93788177 |
47 | CJUN_26792858_Chip-Seq_BT549_Human | 1.92944361 |
48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90950416 |
49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.88541840 |
50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87261091 |
51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86815598 |
52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85830236 |
53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85715090 |
54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.85252282 |
55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.85252282 |
56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85250799 |
57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.81565823 |
58 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.81565823 |
59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.80368724 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.78502339 |
61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76449356 |
62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75495384 |
63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73970284 |
64 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73338359 |
65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73215610 |
66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.72745592 |
67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.72424449 |
68 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.71926481 |
69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71623148 |
70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67021435 |
71 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.66510784 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.59751498 |
73 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58791863 |
74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.55365711 |
75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54139275 |
76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.53370898 |
77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52338646 |
78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50811230 |
79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.50774067 |
80 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49391078 |
81 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48778916 |
82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.47946853 |
83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47662705 |
84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44273788 |
85 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43846127 |
86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43129231 |
87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42293339 |
88 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.42263832 |
89 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40456760 |
90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38921895 |
91 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36779987 |
92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35753242 |
93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34846991 |
94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34598419 |
95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.33449109 |
96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30086341 |
97 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.29714221 |
98 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.29464446 |
99 | GATA2_19941826_ChIP-Seq_K562_Human | 1.28455156 |
100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27380932 |
101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26747334 |
102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26357300 |
103 | MAF_26560356_Chip-Seq_TH2_Human | 1.24330446 |
104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22543078 |
105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22335509 |
106 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.21929360 |
107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.21929360 |
108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21749391 |
109 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20409423 |
110 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20064410 |
111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19501164 |
112 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17065288 |
113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16926847 |
114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15462661 |
115 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15294312 |
116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14394730 |
117 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.12958509 |
118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11866944 |
119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11685123 |
120 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11490127 |
121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11060904 |
122 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10837874 |
123 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09277264 |
124 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08670525 |
125 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08469131 |
126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08266668 |
127 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07623046 |
128 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07581493 |
129 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.07449853 |
130 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07130279 |
131 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.05833879 |
132 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04955468 |
133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04076478 |
134 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03051393 |
135 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.00426587 |
136 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.00107223 |
137 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99598669 |
138 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99395195 |
139 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98612633 |
140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97545013 |
141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97350019 |
142 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97259792 |
143 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.96040100 |
144 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95987675 |
145 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95081124 |
146 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.95047946 |
147 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95002762 |
148 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94647584 |
149 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93723343 |
150 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93406214 |
151 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92560338 |
152 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91849524 |
153 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90494183 |
154 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90381031 |
155 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89940332 |
156 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89921695 |
157 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89408460 |
158 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.89154182 |
159 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.88818221 |
160 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87265189 |
161 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86709830 |
162 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85506630 |
163 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85263436 |
164 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85248828 |
165 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84791032 |
166 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84318506 |
167 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84154138 |
168 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.83320547 |
169 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82601308 |
170 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82422260 |
171 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.82317742 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 4.83423578 |
2 | MP0009780_abnormal_chondrocyte_physiolo | 3.73527567 |
3 | MP0003300_gastrointestinal_ulcer | 3.62656496 |
4 | MP0001835_abnormal_antigen_presentation | 3.30114891 |
5 | MP0003303_peritoneal_inflammation | 2.96359576 |
6 | MP0005275_abnormal_skin_tensile | 2.95062592 |
7 | MP0002396_abnormal_hematopoietic_system | 2.90581512 |
8 | MP0004272_abnormal_basement_membrane | 2.87991064 |
9 | MP0001800_abnormal_humoral_immune | 2.75728267 |
10 | MP0000685_abnormal_immune_system | 2.53811637 |
11 | MP0002877_abnormal_melanocyte_morpholog | 2.51325275 |
12 | MP0001790_abnormal_immune_system | 2.49570350 |
13 | MP0005387_immune_system_phenotype | 2.49570350 |
14 | MP0002166_altered_tumor_susceptibility | 2.47049285 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.43546406 |
16 | MP0002452_abnormal_antigen_presenting | 2.42564328 |
17 | MP0009278_abnormal_bone_marrow | 2.41996102 |
18 | MP0006054_spinal_hemorrhage | 2.34387956 |
19 | MP0005671_abnormal_response_to | 2.33354172 |
20 | MP0000465_gastrointestinal_hemorrhage | 2.26387742 |
21 | MP0005464_abnormal_platelet_physiology | 2.24147701 |
22 | MP0004808_abnormal_hematopoietic_stem | 2.23742796 |
23 | MP0003329_amyloid_beta_deposits | 2.16812530 |
24 | MP0002723_abnormal_immune_serum | 2.10912885 |
25 | MP0001873_stomach_inflammation | 2.09531851 |
26 | MP0002420_abnormal_adaptive_immunity | 2.09412503 |
27 | MP0002398_abnormal_bone_marrow | 2.08079935 |
28 | MP0005000_abnormal_immune_tolerance | 2.07867268 |
29 | MP0001819_abnormal_immune_cell | 2.06985273 |
30 | MP0005058_abnormal_lysosome_morphology | 2.03242883 |
31 | MP0008004_abnormal_stomach_pH | 2.02338118 |
32 | MP0003436_decreased_susceptibility_to | 1.95760448 |
33 | MP0005397_hematopoietic_system_phenotyp | 1.94611964 |
34 | MP0001545_abnormal_hematopoietic_system | 1.94611964 |
35 | MP0000689_abnormal_spleen_morphology | 1.93337700 |
36 | MP0002419_abnormal_innate_immunity | 1.90491530 |
37 | MP0003950_abnormal_plasma_membrane | 1.89506989 |
38 | MP0000716_abnormal_immune_system | 1.86629278 |
39 | MP0005025_abnormal_response_to | 1.86481836 |
40 | MP0010155_abnormal_intestine_physiology | 1.86329196 |
41 | MP0008260_abnormal_autophagy | 1.81820021 |
42 | MP0009785_altered_susceptibility_to | 1.78109529 |
43 | MP0002722_abnormal_immune_system | 1.73810480 |
44 | MP0005623_abnormal_meninges_morphology | 1.72519733 |
45 | MP0006082_CNS_inflammation | 1.71754233 |
46 | MP0005164_abnormal_response_to | 1.63719581 |
47 | MP0000604_amyloidosis | 1.63280672 |
48 | MP0002295_abnormal_pulmonary_circulatio | 1.62714783 |
49 | MP0002429_abnormal_blood_cell | 1.62706957 |
50 | MP0003724_increased_susceptibility_to | 1.62547252 |
51 | MP0005409_darkened_coat_color | 1.61969196 |
52 | MP0001879_abnormal_lymphatic_vessel | 1.60735736 |
53 | MP0004947_skin_inflammation | 1.59872179 |
54 | MP0002006_tumorigenesis | 1.57853935 |
55 | MP0004859_abnormal_synaptic_plasticity | 1.57410671 |
56 | MP0001853_heart_inflammation | 1.54525301 |
57 | MP0002060_abnormal_skin_morphology | 1.51686329 |
58 | MP0001845_abnormal_inflammatory_respons | 1.49814665 |
59 | MP0005165_increased_susceptibility_to | 1.46902980 |
60 | MP0003172_abnormal_lysosome_physiology | 1.45962613 |
61 | MP0003866_abnormal_defecation | 1.45389366 |
62 | MP0002148_abnormal_hypersensitivity_rea | 1.43967667 |
63 | MP0000013_abnormal_adipose_tissue | 1.43235225 |
64 | MP0002405_respiratory_system_inflammati | 1.42723130 |
65 | MP0010234_abnormal_vibrissa_follicle | 1.41807433 |
66 | MP0003566_abnormal_cell_adhesion | 1.41469579 |
67 | MP0001542_abnormal_bone_strength | 1.40902735 |
68 | MP0003763_abnormal_thymus_physiology | 1.39152141 |
69 | MP0010352_gastrointestinal_tract_polyps | 1.35700320 |
70 | MP0005310_abnormal_salivary_gland | 1.33919330 |
71 | MP0002896_abnormal_bone_mineralization | 1.33786249 |
72 | MP0003868_abnormal_feces_composition | 1.33279699 |
73 | MP0000490_abnormal_crypts_of | 1.33050570 |
74 | MP0005503_abnormal_tendon_morphology | 1.32062518 |
75 | MP0000703_abnormal_thymus_morphology | 1.31336984 |
76 | MP0010386_abnormal_urinary_bladder | 1.28645640 |
77 | MP0001533_abnormal_skeleton_physiology | 1.27584787 |
78 | MP0003828_pulmonary_edema | 1.27461646 |
79 | MP0000920_abnormal_myelination | 1.26047167 |
80 | MP0003656_abnormal_erythrocyte_physiolo | 1.24087346 |
81 | MP0004270_analgesia | 1.20703043 |
82 | MP0010368_abnormal_lymphatic_system | 1.20314094 |
83 | MP0003045_fibrosis | 1.20253678 |
84 | MP0004147_increased_porphyrin_level | 1.17676473 |
85 | MP0008469_abnormal_protein_level | 1.17407672 |
86 | MP0001851_eye_inflammation | 1.12168486 |
87 | MP0000751_myopathy | 1.09258388 |
88 | MP0005257_abnormal_intraocular_pressure | 1.08603409 |
89 | MP0000343_altered_response_to | 1.08188535 |
90 | MP0009333_abnormal_splenocyte_physiolog | 1.05568870 |
91 | MP0010329_abnormal_lipoprotein_level | 1.04033137 |
92 | MP0004883_abnormal_blood_vessel | 1.03065020 |
93 | MP0002933_joint_inflammation | 1.02800529 |
94 | MP0000003_abnormal_adipose_tissue | 1.02333246 |
95 | MP0002136_abnormal_kidney_physiology | 0.99816467 |
96 | MP0003183_abnormal_peptide_metabolism | 0.99450615 |
97 | MP0003075_altered_response_to | 0.97271449 |
98 | MP0004510_myositis | 0.97252380 |
99 | MP0009840_abnormal_foam_cell | 0.96742981 |
100 | MP0004484_altered_response_of | 0.95613886 |
101 | MP0002909_abnormal_adrenal_gland | 0.95379313 |
102 | MP0002796_impaired_skin_barrier | 0.95055566 |
103 | MP0000249_abnormal_blood_vessel | 0.93603728 |
104 | MP0005670_abnormal_white_adipose | 0.92024639 |
105 | MP0005365_abnormal_bile_salt | 0.91691829 |
106 | MP0005166_decreased_susceptibility_to | 0.91613345 |
107 | MP0003091_abnormal_cell_migration | 0.90310739 |
108 | MP0001243_abnormal_dermal_layer | 0.88489856 |
109 | MP0001663_abnormal_digestive_system | 0.86061533 |
110 | MP0008874_decreased_physiological_sensi | 0.86007694 |
111 | MP0002019_abnormal_tumor_incidence | 0.84095020 |
112 | MP0005167_abnormal_blood-brain_barrier | 0.83772656 |
113 | MP0010307_abnormal_tumor_latency | 0.83409758 |
114 | MP0002332_abnormal_exercise_endurance | 0.83229891 |
115 | MP0002928_abnormal_bile_duct | 0.83094398 |
116 | MP0004130_abnormal_muscle_cell | 0.83062832 |
117 | MP0008961_abnormal_basal_metabolism | 0.82190637 |
118 | MP0005595_abnormal_vascular_smooth | 0.81741255 |
119 | MP0005076_abnormal_cell_differentiation | 0.81151670 |
120 | MP0004084_abnormal_cardiac_muscle | 0.80638658 |
121 | MP0002998_abnormal_bone_remodeling | 0.80361274 |
122 | MP0009643_abnormal_urine_homeostasis | 0.80282688 |
123 | MP0001915_intracranial_hemorrhage | 0.80279144 |
124 | MP0001958_emphysema | 0.80051167 |
125 | MP0003879_abnormal_hair_cell | 0.79563317 |
126 | MP0005174_abnormal_tail_pigmentation | 0.79544834 |
127 | MP0000767_abnormal_smooth_muscle | 0.78318154 |
128 | MP0003448_altered_tumor_morphology | 0.78185689 |
129 | MP0005023_abnormal_wound_healing | 0.78126923 |
130 | MP0006138_congestive_heart_failure | 0.77068914 |
131 | MP0002133_abnormal_respiratory_system | 0.76720017 |
132 | MP0005388_respiratory_system_phenotype | 0.76720017 |
133 | MP0002971_abnormal_brown_adipose | 0.76253742 |
134 | MP0003279_aneurysm | 0.76162176 |
135 | MP0004185_abnormal_adipocyte_glucose | 0.76041571 |
136 | MP0005621_abnormal_cell_physiology | 0.75940302 |
137 | MP0000609_abnormal_liver_physiology | 0.74841541 |
138 | MP0005375_adipose_tissue_phenotype | 0.74326235 |
139 | MP0000477_abnormal_intestine_morphology | 0.73717271 |
140 | MP0008775_abnormal_heart_ventricle | 0.72167270 |
141 | MP0003453_abnormal_keratinocyte_physiol | 0.71629730 |
142 | MP0001666_abnormal_nutrient_absorption | 0.71328696 |
143 | MP0010771_integument_phenotype | 0.71217794 |
144 | MP0002139_abnormal_hepatobiliary_system | 0.71194637 |
145 | MP0009764_decreased_sensitivity_to | 0.71085129 |
146 | MP0003690_abnormal_glial_cell | 0.70241449 |
147 | MP0003705_abnormal_hypodermis_morpholog | 0.70142575 |
148 | MP0002118_abnormal_lipid_homeostasis | 0.70072833 |
149 | MP0001299_abnormal_eye_distance/ | 0.69395941 |
150 | MP0004782_abnormal_surfactant_physiolog | 0.68701628 |
151 | MP0008569_lethality_at_weaning | 0.68548619 |
152 | MP0004036_abnormal_muscle_relaxation | 0.67756175 |
153 | MP0000639_abnormal_adrenal_gland | 0.66210189 |
154 | MP0000598_abnormal_liver_morphology | 0.65317246 |
155 | MP0000858_altered_metastatic_potential | 0.64945733 |
156 | MP0009046_muscle_twitch | 0.64835992 |
157 | MP0009763_increased_sensitivity_to | 0.64660477 |
158 | MP0003633_abnormal_nervous_system | 0.63587112 |
159 | MP0002009_preneoplasia | 0.63389814 |
160 | MP0005085_abnormal_gallbladder_physiolo | 0.63111921 |
161 | MP0005501_abnormal_skin_physiology | 0.62341648 |
162 | MP0005330_cardiomyopathy | 0.62286359 |
163 | MP0002135_abnormal_kidney_morphology | 0.62174773 |
164 | MP0003635_abnormal_synaptic_transmissio | 0.61626414 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Agammaglobulinemia (HP:0004432) | 5.64337320 |
2 | Cellulitis (HP:0100658) | 5.47037374 |
3 | Verrucae (HP:0200043) | 4.45017253 |
4 | Papilloma (HP:0012740) | 4.45017253 |
5 | Premature rupture of membranes (HP:0001788) | 4.36106773 |
6 | Colitis (HP:0002583) | 4.35129771 |
7 | Recurrent bronchitis (HP:0002837) | 4.07047514 |
8 | Recurrent viral infections (HP:0004429) | 4.06128030 |
9 | Hematochezia (HP:0002573) | 4.04935823 |
10 | Protrusio acetabuli (HP:0003179) | 3.95363526 |
11 | Inflammation of the large intestine (HP:0002037) | 3.93288291 |
12 | Chronic otitis media (HP:0000389) | 3.86495772 |
13 | Gastrointestinal inflammation (HP:0004386) | 3.85755200 |
14 | IgM deficiency (HP:0002850) | 3.77581067 |
15 | Abnormality of B cell number (HP:0010975) | 3.53166399 |
16 | B lymphocytopenia (HP:0010976) | 3.53166399 |
17 | Osteomyelitis (HP:0002754) | 3.49698427 |
18 | Follicular hyperkeratosis (HP:0007502) | 3.47175252 |
19 | Meningitis (HP:0001287) | 3.44538030 |
20 | Spontaneous hematomas (HP:0007420) | 3.43194738 |
21 | Panhypogammaglobulinemia (HP:0003139) | 3.37744137 |
22 | Gastrointestinal stroma tumor (HP:0100723) | 3.34300068 |
23 | Aortic aneurysm (HP:0004942) | 3.27601022 |
24 | Thyroiditis (HP:0100646) | 3.24686012 |
25 | Neurofibrillary tangles (HP:0002185) | 3.23686451 |
26 | Recurrent abscess formation (HP:0002722) | 3.17950384 |
27 | Recurrent fungal infections (HP:0002841) | 3.16348034 |
28 | Interstitial pulmonary disease (HP:0006530) | 3.13585051 |
29 | Vertebral compression fractures (HP:0002953) | 3.09977544 |
30 | Recurrent bacterial skin infections (HP:0005406) | 3.02717847 |
31 | Menorrhagia (HP:0000132) | 3.01572124 |
32 | Abnormality of the nasal mucosa (HP:0000433) | 2.97319071 |
33 | Cerebral aneurysm (HP:0004944) | 2.95587966 |
34 | Systemic lupus erythematosus (HP:0002725) | 2.92238484 |
35 | Thrombocytosis (HP:0001894) | 2.91534773 |
36 | Impaired platelet aggregation (HP:0003540) | 2.89178092 |
37 | Abnormal platelet function (HP:0011869) | 2.89178092 |
38 | Chronic sinusitis (HP:0011109) | 2.88203923 |
39 | Atrophic scars (HP:0001075) | 2.86512580 |
40 | Prolonged bleeding time (HP:0003010) | 2.86458642 |
41 | Supranuclear gaze palsy (HP:0000605) | 2.85937125 |
42 | Cerebral inclusion bodies (HP:0100314) | 2.82100675 |
43 | Increased cerebral lipofuscin (HP:0011813) | 2.78547381 |
44 | Cardiovascular calcification (HP:0011915) | 2.76314547 |
45 | Glomerulonephritis (HP:0000099) | 2.75567338 |
46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.73442876 |
47 | Fatigue (HP:0012378) | 2.69115420 |
48 | Abnormality of the fingertips (HP:0001211) | 2.64642323 |
49 | Dysostosis multiplex (HP:0000943) | 2.63645063 |
50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.63503129 |
51 | Nasal polyposis (HP:0100582) | 2.60675822 |
52 | Eczematoid dermatitis (HP:0000976) | 2.58846231 |
53 | Vascular calcification (HP:0004934) | 2.55385970 |
54 | Wormian bones (HP:0002645) | 2.53762888 |
55 | Gingival bleeding (HP:0000225) | 2.53065400 |
56 | Tetraparesis (HP:0002273) | 2.52382264 |
57 | Increased mean platelet volume (HP:0011877) | 2.50879808 |
58 | Sepsis (HP:0100806) | 2.49175617 |
59 | Lymphopenia (HP:0001888) | 2.48957769 |
60 | Emphysema (HP:0002097) | 2.48346184 |
61 | Glucose intolerance (HP:0000833) | 2.48220533 |
62 | Deep venous thrombosis (HP:0002625) | 2.47719509 |
63 | Recurrent sinusitis (HP:0011108) | 2.47166106 |
64 | Right ventricular cardiomyopathy (HP:0011663) | 2.41937132 |
65 | Petechiae (HP:0000967) | 2.39851696 |
66 | Arterial tortuosity (HP:0005116) | 2.39802618 |
67 | Autoimmune thrombocytopenia (HP:0001973) | 2.38353815 |
68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35024575 |
69 | Myositis (HP:0100614) | 2.34978469 |
70 | Cervical subluxation (HP:0003308) | 2.34639997 |
71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34327867 |
72 | Facial diplegia (HP:0001349) | 2.33247618 |
73 | Hand muscle atrophy (HP:0009130) | 2.32879150 |
74 | Vasculitis (HP:0002633) | 2.32430600 |
75 | Growth hormone excess (HP:0000845) | 2.31883902 |
76 | Pustule (HP:0200039) | 2.31416704 |
77 | Upper limb amyotrophy (HP:0009129) | 2.30334158 |
78 | Distal upper limb amyotrophy (HP:0007149) | 2.30334158 |
79 | Recurrent skin infections (HP:0001581) | 2.27733693 |
80 | Vacuolated lymphocytes (HP:0001922) | 2.27370110 |
81 | Autoamputation (HP:0001218) | 2.26460809 |
82 | Action tremor (HP:0002345) | 2.25196897 |
83 | Mitral stenosis (HP:0001718) | 2.22254634 |
84 | Myocardial infarction (HP:0001658) | 2.21404571 |
85 | Peritonitis (HP:0002586) | 2.21009170 |
86 | Abnormality of T cell physiology (HP:0011840) | 2.20963003 |
87 | Recurrent pneumonia (HP:0006532) | 2.20838631 |
88 | Polycythemia (HP:0001901) | 2.19836538 |
89 | Bronchitis (HP:0012387) | 2.19388840 |
90 | T lymphocytopenia (HP:0005403) | 2.19301382 |
91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.19051302 |
92 | Insidious onset (HP:0003587) | 2.18089404 |
93 | Termporal pattern (HP:0011008) | 2.18089404 |
94 | Mucopolysacchariduria (HP:0008155) | 2.17922991 |
95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17922991 |
96 | Abnormality of T cells (HP:0002843) | 2.17006080 |
97 | Epistaxis (HP:0000421) | 2.15140956 |
98 | Alopecia of scalp (HP:0002293) | 2.14864781 |
99 | Increased IgE level (HP:0003212) | 2.13497771 |
100 | Eosinophilia (HP:0001880) | 2.13351244 |
101 | Ankle contracture (HP:0006466) | 2.10944931 |
102 | Fragile skin (HP:0001030) | 2.10460743 |
103 | Hypoplasia of the thymus (HP:0000778) | 2.09857337 |
104 | Vascular tortuosity (HP:0004948) | 2.09817102 |
105 | Osteolytic defects of the hand bones (HP:0009699) | 2.09056246 |
106 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09056246 |
107 | Chronic diarrhea (HP:0002028) | 2.08859151 |
108 | Dilatation of the ascending aorta (HP:0005111) | 2.08853120 |
109 | Short nail (HP:0001799) | 2.07425636 |
110 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06865197 |
111 | Complement deficiency (HP:0004431) | 2.05822547 |
112 | Arterial thrombosis (HP:0004420) | 2.05806354 |
113 | IgA deficiency (HP:0002720) | 2.05056647 |
114 | Aortic dissection (HP:0002647) | 2.03746453 |
115 | Spondylolisthesis (HP:0003302) | 2.03020763 |
116 | Recurrent cutaneous fungal infections (HP:0011370) | 2.02442263 |
117 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.02442263 |
118 | Abnormality of T cell number (HP:0011839) | 2.02087676 |
119 | Restrictive lung disease (HP:0002091) | 2.00456781 |
120 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.99270308 |
121 | Skin ulcer (HP:0200042) | 1.99238169 |
122 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97266106 |
123 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97266106 |
124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97266106 |
125 | Small epiphyses (HP:0010585) | 1.96743355 |
126 | Periodontitis (HP:0000704) | 1.96722524 |
127 | Abnormal platelet volume (HP:0011876) | 1.96316721 |
128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96183199 |
129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96183199 |
130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96183199 |
131 | Nephritis (HP:0000123) | 1.94772994 |
132 | Skin rash (HP:0000988) | 1.94562451 |
133 | Papilledema (HP:0001085) | 1.94421423 |
134 | Disinhibition (HP:0000734) | 1.94118369 |
135 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93803699 |
136 | Striae distensae (HP:0001065) | 1.93441294 |
137 | Aneurysm (HP:0002617) | 1.93136991 |
138 | Scanning speech (HP:0002168) | 1.91399724 |
139 | Abnormal delivery (HP:0001787) | 1.91377264 |
140 | Abnormality of the thoracic spine (HP:0100711) | 1.90926119 |
141 | Ankyloglossia (HP:0010296) | 1.90808353 |
142 | Granulocytopenia (HP:0001913) | 1.90147946 |
143 | Papillary thyroid carcinoma (HP:0002895) | 1.89357974 |
144 | Chest pain (HP:0100749) | 1.88963188 |
145 | Purpura (HP:0000979) | 1.86636005 |
146 | Distal lower limb amyotrophy (HP:0008944) | 1.83895351 |
147 | Amyloidosis (HP:0011034) | 1.83690815 |
148 | Menstrual irregularities (HP:0000858) | 1.83307717 |
149 | Abnormal glucose tolerance (HP:0001952) | 1.82583355 |
150 | Blue sclerae (HP:0000592) | 1.78367307 |
151 | Skin nodule (HP:0200036) | 1.75439182 |
152 | Abnormality of oral frenula (HP:0000190) | 1.74773933 |
153 | Metaphyseal dysplasia (HP:0100255) | 1.72736596 |
154 | Hypokinesia (HP:0002375) | 1.72673140 |
155 | Intention tremor (HP:0002080) | 1.71584604 |
156 | Nuclear cataract (HP:0100018) | 1.71399695 |
157 | Joint hemorrhage (HP:0005261) | 1.70654847 |
158 | Abnormality of carpal bone ossification (HP:0006257) | 1.70288657 |
159 | Abnormality of the intrinsic pathway (HP:0010989) | 1.67626109 |
160 | Upper limb muscle weakness (HP:0003484) | 1.67177373 |
161 | Ovoid vertebral bodies (HP:0003300) | 1.66600704 |
162 | Lower limb amyotrophy (HP:0007210) | 1.66523101 |
163 | Spinal rigidity (HP:0003306) | 1.64996347 |
164 | Soft skin (HP:0000977) | 1.64687322 |
165 | Back pain (HP:0003418) | 1.64343068 |
166 | Hyperlipoproteinemia (HP:0010980) | 1.62473260 |
167 | Bladder diverticulum (HP:0000015) | 1.62409922 |
168 | Unilateral renal agenesis (HP:0000122) | 1.62179056 |
169 | Broad face (HP:0000283) | 1.61573090 |
170 | Abnormality of the acetabulum (HP:0003170) | 1.60029406 |
171 | Hyperextensible skin (HP:0000974) | 1.59729073 |
172 | Distal lower limb muscle weakness (HP:0009053) | 1.59687530 |
173 | Axonal loss (HP:0003447) | 1.57184066 |
174 | Hypoalphalipoproteinemia (HP:0003233) | 1.56046813 |
175 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.55738733 |
176 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.55682657 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EEF2K | 4.34174154 |
2 | MAP3K10 | 4.19270284 |
3 | TGFBR2 | 3.92368016 |
4 | MAP4K1 | 3.46387667 |
5 | ERN1 | 3.38499551 |
6 | MAP3K12 | 2.75746448 |
7 | TESK1 | 2.58267476 |
8 | TRIB3 | 2.49597487 |
9 | CSF1R | 2.39357095 |
10 | MYLK | 2.35734230 |
11 | STK10 | 2.26682445 |
12 | PKN2 | 2.22913028 |
13 | PDGFRA | 2.12753062 |
14 | NTRK1 | 2.05384444 |
15 | EPHA2 | 2.04243003 |
16 | MST1R | 2.02766554 |
17 | TYK2 | 2.02352836 |
18 | LATS2 | 2.01299398 |
19 | BLK | 2.00762649 |
20 | LIMK1 | 1.98964616 |
21 | AKT3 | 1.98317687 |
22 | MAP3K2 | 1.95107199 |
23 | GRK6 | 1.94385977 |
24 | MAP3K9 | 1.90204874 |
25 | BTK | 1.87770594 |
26 | LRRK2 | 1.82616277 |
27 | ARAF | 1.79127563 |
28 | STK38 | 1.74452055 |
29 | PTK2 | 1.74288165 |
30 | MET | 1.68898160 |
31 | KIT | 1.66011424 |
32 | FER | 1.64307293 |
33 | SYK | 1.58878448 |
34 | EPHB1 | 1.55133313 |
35 | CAMK1D | 1.53837396 |
36 | JAK1 | 1.53194740 |
37 | SCYL2 | 1.47422018 |
38 | JAK3 | 1.38422955 |
39 | KSR2 | 1.38287018 |
40 | RIPK4 | 1.36861672 |
41 | PAK6 | 1.36427048 |
42 | ZAP70 | 1.36082459 |
43 | TBK1 | 1.35968451 |
44 | ERBB4 | 1.35916378 |
45 | MAP2K3 | 1.30247391 |
46 | CAMKK2 | 1.29296014 |
47 | PTK6 | 1.28057674 |
48 | ITK | 1.26752489 |
49 | MAP3K3 | 1.26651136 |
50 | TAOK3 | 1.25274043 |
51 | MAPKAPK3 | 1.24143865 |
52 | MATK | 1.23778518 |
53 | KDR | 1.22804705 |
54 | CAMK1G | 1.21554339 |
55 | MAP3K6 | 1.20495295 |
56 | SIK1 | 1.16511791 |
57 | CLK1 | 1.14127561 |
58 | RPS6KB2 | 1.12811562 |
59 | FGFR3 | 1.12364817 |
60 | TEC | 1.12219386 |
61 | HCK | 1.11955598 |
62 | EPHA4 | 1.11725209 |
63 | LATS1 | 1.10185684 |
64 | FES | 1.08647313 |
65 | TIE1 | 1.06656129 |
66 | SIK2 | 1.06638766 |
67 | KSR1 | 1.06227409 |
68 | FRK | 1.05849796 |
69 | NTRK3 | 1.05728948 |
70 | PDGFRB | 1.04208117 |
71 | CDK12 | 1.03479058 |
72 | PAK3 | 1.03262245 |
73 | DDR2 | 1.03215801 |
74 | SIK3 | 1.02498528 |
75 | RIPK1 | 1.01744687 |
76 | LYN | 0.99932925 |
77 | PLK2 | 0.99646313 |
78 | MOS | 0.98675063 |
79 | CDK6 | 0.98286082 |
80 | BMPR2 | 0.97474317 |
81 | PRPF4B | 0.97165951 |
82 | PTK2B | 0.93215627 |
83 | LCK | 0.91829025 |
84 | DAPK2 | 0.91350911 |
85 | CSK | 0.91252068 |
86 | STK4 | 0.90554574 |
87 | GRK5 | 0.90538184 |
88 | PAK4 | 0.90434893 |
89 | ERBB3 | 0.90243117 |
90 | EIF2AK1 | 0.90063945 |
91 | TGFBR1 | 0.89672334 |
92 | CDK4 | 0.89652666 |
93 | MINK1 | 0.89180212 |
94 | FGFR4 | 0.88847470 |
95 | PRKD3 | 0.87527018 |
96 | JAK2 | 0.86591547 |
97 | MAPK12 | 0.86245515 |
98 | CDK9 | 0.85018016 |
99 | FLT3 | 0.84322434 |
100 | NEK6 | 0.82956144 |
101 | PIM1 | 0.80296055 |
102 | MAP3K1 | 0.79948077 |
103 | MAPK11 | 0.77193820 |
104 | TRPM7 | 0.75292550 |
105 | MAPK15 | 0.73538758 |
106 | NEK2 | 0.72238859 |
107 | NEK9 | 0.70562221 |
108 | IRAK4 | 0.70258086 |
109 | BCR | 0.68818512 |
110 | ROCK2 | 0.67720208 |
111 | RPS6KA4 | 0.67709566 |
112 | SGK3 | 0.66660847 |
113 | YES1 | 0.66526975 |
114 | MAPK4 | 0.66218707 |
115 | MAP3K7 | 0.66191187 |
116 | IKBKE | 0.65248789 |
117 | TTN | 0.65122851 |
118 | RAF1 | 0.64864777 |
119 | MARK1 | 0.64845585 |
120 | PDK1 | 0.64143432 |
121 | PRKG2 | 0.63895922 |
122 | IRAK3 | 0.63737495 |
123 | MAP2K1 | 0.62008622 |
124 | IKBKB | 0.61712041 |
125 | MST4 | 0.60580285 |
126 | PHKG1 | 0.59738078 |
127 | PHKG2 | 0.59738078 |
128 | HIPK2 | 0.59576549 |
129 | PAK2 | 0.59394835 |
130 | CAMK2B | 0.58473080 |
131 | MAP3K13 | 0.54958140 |
132 | MARK2 | 0.53839798 |
133 | MAP3K5 | 0.53765484 |
134 | MAP3K8 | 0.52690689 |
135 | CAMK2G | 0.52345512 |
136 | ICK | 0.50909639 |
137 | MARK3 | 0.50814990 |
138 | TNK2 | 0.50546105 |
139 | ABL2 | 0.50371652 |
140 | PIK3CG | 0.50195619 |
141 | CAMK2D | 0.49929014 |
142 | PRKD1 | 0.49876265 |
143 | PRKCE | 0.49314772 |
144 | DAPK1 | 0.46950196 |
145 | PRKD2 | 0.46916039 |
146 | RET | 0.46665726 |
147 | STK3 | 0.46559486 |
148 | NLK | 0.45768018 |
149 | FGFR2 | 0.44144777 |
150 | CDK14 | 0.44110926 |
151 | EPHA3 | 0.44025785 |
152 | WNK1 | 0.42907434 |
153 | MAP3K14 | 0.42893162 |
154 | MAPKAPK2 | 0.42728086 |
155 | CDK5 | 0.42385780 |
156 | CDK18 | 0.42179231 |
157 | MAPKAPK5 | 0.41898092 |
158 | LMTK2 | 0.41657700 |
159 | STK38L | 0.41434471 |
160 | ILK | 0.41343103 |
161 | DMPK | 0.41316180 |
162 | EGFR | 0.41206121 |
163 | DYRK1B | 0.39420586 |
164 | PDPK1 | 0.36430526 |
165 | MELK | 0.35372691 |
166 | TXK | 0.34373923 |
167 | PRKCH | 0.32937554 |
168 | STK39 | 0.32833092 |
169 | ABL1 | 0.31676532 |
170 | PRKAA2 | 0.31128979 |
Rank | Gene Set | Z-score |
---|---|---|
1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.90280462 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.53326179 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52855208 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.18889063 |
5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.12655946 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04650280 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97482971 |
8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95354202 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89015408 |
10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.88753579 |
11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.86672442 |
12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84934770 |
13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.80462036 |
14 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.79102438 |
15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.75908718 |
16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.75505127 |
17 | Platelet activation_Homo sapiens_hsa04611 | 1.74406405 |
18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74350244 |
19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70948246 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69228676 |
21 | Measles_Homo sapiens_hsa05162 | 1.59224534 |
22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.55263026 |
23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47062048 |
24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46931553 |
25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45759904 |
26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40957839 |
27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39509896 |
28 | Lysosome_Homo sapiens_hsa04142 | 1.36205586 |
29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35440303 |
30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.35001196 |
31 | Pertussis_Homo sapiens_hsa05133 | 1.33542667 |
32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31009994 |
33 | Tuberculosis_Homo sapiens_hsa05152 | 1.29156809 |
34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29074792 |
35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29030306 |
36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27639597 |
37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.27144875 |
38 | Hepatitis B_Homo sapiens_hsa05161 | 1.25771285 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24614922 |
40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20563983 |
41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20560186 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17398559 |
43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16028545 |
44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15509464 |
45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14747171 |
46 | Influenza A_Homo sapiens_hsa05164 | 1.12146829 |
47 | Shigellosis_Homo sapiens_hsa05131 | 1.11318661 |
48 | Apoptosis_Homo sapiens_hsa04210 | 1.09541893 |
49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07783200 |
50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07417932 |
51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04452484 |
52 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.04265013 |
53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.02351275 |
54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01731369 |
55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01669694 |
56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01214360 |
57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00632108 |
58 | Malaria_Homo sapiens_hsa05144 | 0.99648776 |
59 | Renin secretion_Homo sapiens_hsa04924 | 0.99229210 |
60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97863530 |
61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96668453 |
62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94834751 |
63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94319686 |
64 | Prion diseases_Homo sapiens_hsa05020 | 0.94222931 |
65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93965394 |
66 | Insulin resistance_Homo sapiens_hsa04931 | 0.92364721 |
67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89690241 |
68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89470141 |
69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88971056 |
70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88781630 |
71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87501080 |
72 | Focal adhesion_Homo sapiens_hsa04510 | 0.87494081 |
73 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87251447 |
74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86867654 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86406809 |
76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85713243 |
77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85566728 |
78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85515279 |
79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85467866 |
80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85249394 |
81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85205464 |
82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84391969 |
83 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82669173 |
84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82536403 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.82033027 |
86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81656724 |
87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81405827 |
88 | Legionellosis_Homo sapiens_hsa05134 | 0.81228344 |
89 | Gap junction_Homo sapiens_hsa04540 | 0.80636647 |
90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80461319 |
91 | Hepatitis C_Homo sapiens_hsa05160 | 0.80425889 |
92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.79707133 |
93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77709572 |
94 | Insulin secretion_Homo sapiens_hsa04911 | 0.77701642 |
95 | Salmonella infection_Homo sapiens_hsa05132 | 0.76041500 |
96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76019307 |
97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75945320 |
98 | Glioma_Homo sapiens_hsa05214 | 0.75227536 |
99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74068942 |
100 | ABC transporters_Homo sapiens_hsa02010 | 0.73850359 |
101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73681499 |
102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72760752 |
103 | Salivary secretion_Homo sapiens_hsa04970 | 0.72569177 |
104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72533826 |
105 | Bile secretion_Homo sapiens_hsa04976 | 0.72432996 |
106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72262500 |
107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72160399 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71438715 |
109 | Long-term depression_Homo sapiens_hsa04730 | 0.71388520 |
110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70909024 |
111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70721734 |
112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70647613 |
113 | Mineral absorption_Homo sapiens_hsa04978 | 0.70635168 |
114 | Phagosome_Homo sapiens_hsa04145 | 0.70120555 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69791644 |
116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69725145 |
117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69134856 |
118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68867051 |
119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68845054 |
120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67122385 |
121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66644014 |
122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66233121 |
123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64876713 |
124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64433344 |
125 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64131791 |
126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62663296 |
127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62369011 |
128 | Amoebiasis_Homo sapiens_hsa05146 | 0.61713162 |
129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61487401 |
130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60895080 |
131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60336706 |
132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59335522 |
133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59252690 |
134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59131256 |
135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58304838 |
136 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.58222457 |
137 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58218844 |
138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58170708 |
139 | Lysine degradation_Homo sapiens_hsa00310 | 0.57903972 |
140 | Prostate cancer_Homo sapiens_hsa05215 | 0.57444001 |
141 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57158559 |
142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56934548 |
143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55718734 |
144 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55016037 |
145 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54466619 |
146 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54332533 |
147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54078384 |
148 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54072089 |
149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53524666 |
150 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52849667 |
151 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52678113 |
152 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52108823 |
153 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44657896 |
154 | Adherens junction_Homo sapiens_hsa04520 | 0.44152880 |
155 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43062348 |
156 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42649228 |
157 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42190867 |
158 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41707190 |
159 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41418745 |